WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NASDAQ: NURO) reported today the Quell®
app is now available in Google Play. Quell is an over-the-counter
wearable pain relief device that utilizes proprietary non-invasive
neurostimulation technology to provide relief from chronic pain. The
device is designed for people with conditions such as diabetic nerve
pain, low back and leg pain, fibromyalgia and pain associated with
osteoarthritis. The advanced wearable device is lightweight and can be
worn during the day while active, and at night while sleeping. It has
been cleared by the FDA for treatment of chronic pain without a
prescription. In a recent clinical study, 81% of participants rated
Quell as improving their management of chronic pain and overall health,
and 67% reported a reduction in use of pain medications.
The new Android app enhances Quell by providing the user with a
real-time therapy dashboard, therapy and sleep tracking. Quell
communicates with mobile devices running the app through Bluetooth®
low energy. There is also a Quell iOS app available on the Apple app
store.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. For more information, please visit www.QuellRelief.com
and www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150929006442/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
